155 related articles for article (PubMed ID: 29389069)
1. Proteomics with Mass Spectrometry Imaging: Beyond Amyloid Typing.
Lavatelli F; Merlini G
Proteomics; 2018 Apr; 18(7):e1700353. PubMed ID: 29389069
[TBL] [Abstract][Full Text] [Related]
2. MALDI Mass Spectrometry Imaging: A Novel Tool for the Identification and Classification of Amyloidosis.
Winter M; Tholey A; Kristen A; Röcken C
Proteomics; 2017 Nov; 17(22):. PubMed ID: 28994248
[TBL] [Abstract][Full Text] [Related]
3. Imaging mass spectrometry analysis of renal amyloidosis biopsies reveals protein co-localization with amyloid deposits.
Casadonte R; Kriegsmann M; Deininger SO; Amann K; Paape R; Belau E; Suckau D; Fuchser J; Beckmann J; Becker M; Kriegsmann J
Anal Bioanal Chem; 2015 Jul; 407(18):5323-31. PubMed ID: 25935672
[TBL] [Abstract][Full Text] [Related]
4. Topologies of amyloidogenic proteins in Congo red-positive sliced sections of formalin-fixed paraffin embedded tissues by MALDI-MS imaging coupled with on-tissue tryptic digestion.
Nakanishi T; Ito M; Nirasawa T; Tsuji M; Takubo T
Clin Biochem; 2013 Oct; 46(15):1595-600. PubMed ID: 23732480
[TBL] [Abstract][Full Text] [Related]
5. MALDI mass spectrometry imaging unravels organ and amyloid-type specific peptide signatures in pulmonary and gastrointestinal amyloidosis.
Schürmann J; Gottwald J; Rottenaicher G; Tholey A; Röcken C
Proteomics Clin Appl; 2021 Nov; 15(6):e2000079. PubMed ID: 34061454
[TBL] [Abstract][Full Text] [Related]
6. [Clinical Laboratory Test Using Proteomics: The Usefulness of Proteomic Techniques for Amyloid Typing].
Tasaki M; Obayashi K; Ando Y
Rinsho Byori; 2015 Aug; 63(8):980-5. PubMed ID: 26638436
[TBL] [Abstract][Full Text] [Related]
7. Proteomics and mass spectrometry in the diagnosis of renal amyloidosis.
Picken MM
Clin Kidney J; 2015 Dec; 8(6):665-72. PubMed ID: 26613021
[TBL] [Abstract][Full Text] [Related]
8. How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing.
Leung N; Nasr SH; Sethi S
Blood; 2012 Oct; 120(16):3206-13. PubMed ID: 22948045
[TBL] [Abstract][Full Text] [Related]
9. Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue.
Lavatelli F; Perlman DH; Spencer B; Prokaeva T; McComb ME; Théberge R; Connors LH; Bellotti V; Seldin DC; Merlini G; Skinner M; Costello CE
Mol Cell Proteomics; 2008 Aug; 7(8):1570-83. PubMed ID: 18474516
[TBL] [Abstract][Full Text] [Related]
10. Precise diagnosis and typing of early-stage renal immunoglobulin-derived amyloidosis by label-free quantification of parallel reaction monitoring-based targeted proteomics.
Li Y; Zhang Y; Zhou X; Xue X; Wang M; Kang D; Zhou Y; Hu R; Quan S; Xing G; Yang J
BMC Nephrol; 2023 Mar; 24(1):50. PubMed ID: 36894904
[TBL] [Abstract][Full Text] [Related]
11. Classification of Amyloidosis by Model-Assisted Mass Spectrometry-Based Proteomics.
Palstrøm NB; Rojek AM; Møller HEH; Hansen CT; Matthiesen R; Rasmussen LM; Abildgaard N; Beck HC
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008745
[TBL] [Abstract][Full Text] [Related]
12. Clinical proteomics for diagnosis and typing of systemic amyloidoses.
Brambilla F; Lavatelli F; Merlini G; Mauri P
Proteomics Clin Appl; 2013 Jan; 7(1-2):136-43. PubMed ID: 23184874
[TBL] [Abstract][Full Text] [Related]
13. Proteomic typing of amyloid deposits in systemic amyloidoses.
Lavatelli F; Vrana JA
Amyloid; 2011 Dec; 18(4):177-82. PubMed ID: 22080761
[TBL] [Abstract][Full Text] [Related]
14. [Classification of amyloidosis by laser micro-dissection and mass spectrometry based proteomic analysis].
Shen K; Sun W; Sun J; Sun W; Zhong D; Cao X; Zhou D; Li J
Zhonghua Xue Ye Xue Za Zhi; 2015 Feb; 36(2):99-102. PubMed ID: 25778882
[TBL] [Abstract][Full Text] [Related]
15. Establishing the fluorescent amyloid ligand h-FTAA for studying human tissues with systemic and localized amyloid.
Sjölander D; Röcken C; Westermark P; Westermark GT; Nilsson KP; Hammarström P
Amyloid; 2016 Jun; 23(2):98-108. PubMed ID: 26987044
[TBL] [Abstract][Full Text] [Related]
16. MALDI-mass spectrometry imaging identifies vitronectin as a common constituent of amyloid deposits.
Winter M; Tholey A; Krüger S; Schmidt H; Röcken C
J Histochem Cytochem; 2015 Oct; 63(10):772-9. PubMed ID: 26101327
[TBL] [Abstract][Full Text] [Related]
17. Effect of dynamic exclusion and the use of FAIMS, DIA and MALDI-mass spectrometry imaging with ion mobility on amyloid protein identification.
Aguilan JT; Lim J; Racine-Brzostek S; Fischer J; Silvescu C; Cornett S; Nieves E; Mendu DR; Aliste CM; Semple S; Angeletti R; Weiss LM; Cole A; Prystowsky M; Pullman J; Sidoli S
Clin Proteomics; 2024 Jul; 21(1):47. PubMed ID: 38961380
[TBL] [Abstract][Full Text] [Related]
18. N-terminal peptide fragment constitutes core of amyloid deposition of serum amyloid A: An imaging mass spectrometry study.
Shintani-Domoto Y; Sugiura Y; Ogawa M; Sugiyama E; Abe H; Sakatani T; Ohashi R; Ushiku T; Fukayama M
PLoS One; 2022; 17(10):e0275993. PubMed ID: 36240260
[TBL] [Abstract][Full Text] [Related]
19. New insights into systemic amyloidosis: the importance of diagnosis of specific type.
Picken MM
Curr Opin Nephrol Hypertens; 2007 May; 16(3):196-203. PubMed ID: 17420662
[TBL] [Abstract][Full Text] [Related]
20. Identification and location of a cysteinyl posttranslational modification in an amyloidogenic kappa1 light chain protein by electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry.
Lim A; Wally J; Walsh MT; Skinner M; Costello CE
Anal Biochem; 2001 Aug; 295(1):45-56. PubMed ID: 11476544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
